{"id":"https://openalex.org/W2045465355","doi":"https://doi.org/10.14694/edbook_am.2014.34.e353","title":"Management and Future Directions in Non-Small Cell Lung Cancer with Known Activating Mutations","display_name":"Management and Future Directions in Non-Small Cell Lung Cancer with Known Activating Mutations","alternate_titles":[],"publication_year":2014,"publication_date":"2014-05-01","ids":{"openalex":"https://openalex.org/W2045465355","doi":"https://doi.org/10.14694/edbook_am.2014.34.e353","mag":"2045465355","pmid":"https://pubmed.ncbi.nlm.nih.gov/24857124"},"language":"en","primary_location":{"id":"doi:10.14694/edbook_am.2014.34.e353","doi":"https://doi.org/10.14694/edbook_am.2014.34.e353","is_oa":false,"landing_page_url":"https://doi.org/10.14694/edbook_am.2014.34.e353","pdf_url":null,"source":{"id":"https://openalex.org/S4210215109","display_name":"American Society of Clinical Oncology Educational Book","issn_l":"1548-8748","issn":["1548-8748","1548-8756","1930-7020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","ki-jl-1","medline","poland-40","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320068","host_organization_name":"American Society of Clinical Oncology","host_organization_lineage":["https://openalex.org/P4310320068"],"host_organization_lineage_names":["American Society of Clinical Oncology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Society of Clinical Oncology Educational Book","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2045465355"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055537555","display_name":"David E. Gerber","orcid":"https://orcid.org/0000-0002-7812-6741","observed_orcids":["https://orcid.org/0000-0002-7812-6741"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David E. Gerber","raw_affiliation_strings":["From the Department of Medicine, Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, TX; Department of Medical Oncology, Thoracic Oncology Section, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Department of Medicine, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Medicine, Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, TX; Department of Medical Oncology, Thoracic Oncology Section, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Department of Medicine, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020504047","display_name":"Leena Gandhi","orcid":"https://orcid.org/0000-0002-2398-9179","observed_orcids":["https://orcid.org/0000-0002-2398-9179"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Leena Gandhi","raw_affiliation_strings":["From the Department of Medicine, Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, TX; Department of Medical Oncology, Thoracic Oncology Section, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Department of Medicine, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Medicine, Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, TX; Department of Medical Oncology, Thoracic Oncology Section, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Department of Medicine, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I867280407"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042156692","display_name":"Daniel Botelho Costa","orcid":"https://orcid.org/0000-0002-0689-395X","observed_orcids":["https://orcid.org/0000-0002-0689-395X"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Daniel B. Costa","raw_affiliation_strings":["From the Department of Medicine, Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, TX; Department of Medical Oncology, Thoracic Oncology Section, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Department of Medicine, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Medicine, Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, TX; Department of Medical Oncology, Thoracic Oncology Section, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Department of Medicine, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I1316535847","https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I867280407"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.3584,"has_fulltext":false,"cited_by_count":93,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.9160056,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":100},"biblio":{"volume":null,"issue":"34","first_page":"e353","last_page":"e365"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":1.0},{"id":"https://openalex.org/keywords/actionable-driver-mutations","display_name":"actionable driver mutations","score":0.7039999961853027},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9549999833106995},{"id":"https://openalex.org/keywords/egfr-mutation","display_name":"EGFR mutation","score":0.9810000061988831},{"id":"https://openalex.org/keywords/alk-rearrangement","display_name":"ALK rearrangement","score":0.9559999704360962},{"id":"https://openalex.org/keywords/crizotinib","display_name":"crizotinib","score":0.8370000123977661},{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.843999981880188},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.9919999837875366},{"id":"https://openalex.org/keywords/afatinib","display_name":"afatinib","score":0.996999979019165},{"id":"https://openalex.org/keywords/kras","display_name":"KRAS","score":0.46700000762939453},{"id":"https://openalex.org/keywords/ros1","display_name":"ROS1","score":0.9079999923706055},{"id":"https://openalex.org/keywords/ret","display_name":"RET","score":0.7570000290870667},{"id":"https://openalex.org/keywords/braf","display_name":"BRAF","score":0.972000002861023},{"id":"https://openalex.org/keywords/ntrk1","display_name":"NTRK1","score":0.8299999833106995},{"id":"https://openalex.org/keywords/fibroblast-growth-factor-receptor","display_name":"fibroblast growth factor receptor","score":0.8159999847412109},{"id":"https://openalex.org/keywords/precision-oncology","display_name":"precision oncology","score":0.6600000262260437},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7580000162124634},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6660000085830688}],"concepts":[{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6417129039764404},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5197353363037109},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.4546246826648712},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.43828409910202026},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3762222230434418},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.36060580611228943},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3253909647464752}],"mesh":[{"descriptor_ui":"D000069347","descriptor_name":"Erlotinib Hydrochloride","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000077156","descriptor_name":"Gefitinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077192","descriptor_name":"Adenocarcinoma of Lung","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077548","descriptor_name":"Anaplastic Lymphoma Kinase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077716","descriptor_name":"Afatinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009857","descriptor_name":"Oncogenes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018307","descriptor_name":"Neoplasms, Squamous Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D020794","descriptor_name":"Receptor Protein-Tyrosine Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D059645","descriptor_name":"Mutation Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.14694/edbook_am.2014.34.e353","doi":"https://doi.org/10.14694/edbook_am.2014.34.e353","is_oa":false,"landing_page_url":"https://doi.org/10.14694/edbook_am.2014.34.e353","pdf_url":null,"source":{"id":"https://openalex.org/S4210215109","display_name":"American Society of Clinical Oncology Educational Book","issn_l":"1548-8748","issn":["1548-8748","1548-8756","1930-7020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","ki-jl-1","medline","poland-40","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320068","host_organization_name":"American Society of Clinical Oncology","host_organization_lineage":["https://openalex.org/P4310320068"],"host_organization_lineage_names":["American Society of Clinical Oncology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Society of Clinical Oncology Educational Book","raw_type":"journal-article"},{"id":"pmid:24857124","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24857124","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2081079141","display_name":null,"funder_award_id":"CA090578","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":90,"referenced_works":["https://openalex.org/W128078738","https://openalex.org/W438814822","https://openalex.org/W1719751125","https://openalex.org/W1751232375","https://openalex.org/W1970822548","https://openalex.org/W1975784282","https://openalex.org/W1978236936","https://openalex.org/W1988856925","https://openalex.org/W1989116783","https://openalex.org/W1990774346","https://openalex.org/W1996429338","https://openalex.org/W1997476230","https://openalex.org/W1999213748","https://openalex.org/W2002937040","https://openalex.org/W2003984225","https://openalex.org/W2004136952","https://openalex.org/W2006315580","https://openalex.org/W2007661090","https://openalex.org/W2009000810","https://openalex.org/W2018178643","https://openalex.org/W2027114592","https://openalex.org/W2029218729","https://openalex.org/W2030227571","https://openalex.org/W2043696829","https://openalex.org/W2044293524","https://openalex.org/W2050249255","https://openalex.org/W2052705131","https://openalex.org/W2053541213","https://openalex.org/W2055402151","https://openalex.org/W2065141010","https://openalex.org/W2076883919","https://openalex.org/W2081801534","https://openalex.org/W2085137844","https://openalex.org/W2096156234","https://openalex.org/W2096198395","https://openalex.org/W2097026987","https://openalex.org/W2100541925","https://openalex.org/W2108927999","https://openalex.org/W2109788976","https://openalex.org/W2111254482","https://openalex.org/W2111361612","https://openalex.org/W2111662961","https://openalex.org/W2112854176","https://openalex.org/W2113327188","https://openalex.org/W2114032749","https://openalex.org/W2114255370","https://openalex.org/W2114784462","https://openalex.org/W2119886330","https://openalex.org/W2121005606","https://openalex.org/W2122133689","https://openalex.org/W2125735484","https://openalex.org/W2126298634","https://openalex.org/W2127129900","https://openalex.org/W2128339707","https://openalex.org/W2129360604","https://openalex.org/W2130488043","https://openalex.org/W2132157071","https://openalex.org/W2132578211","https://openalex.org/W2133963438","https://openalex.org/W2134607826","https://openalex.org/W2134787029","https://openalex.org/W2136245016","https://openalex.org/W2136549983","https://openalex.org/W2139110945","https://openalex.org/W2139236349","https://openalex.org/W2140333474","https://openalex.org/W2141965353","https://openalex.org/W2144918562","https://openalex.org/W2146418087","https://openalex.org/W2149152398","https://openalex.org/W2150371178","https://openalex.org/W2150424194","https://openalex.org/W2151016309","https://openalex.org/W2152905269","https://openalex.org/W2154402764","https://openalex.org/W2158797210","https://openalex.org/W2159587676","https://openalex.org/W2160304102","https://openalex.org/W2160860814","https://openalex.org/W2160982674","https://openalex.org/W2161817637","https://openalex.org/W2161821474","https://openalex.org/W2162394887","https://openalex.org/W2163798887","https://openalex.org/W2166084034","https://openalex.org/W2166292499","https://openalex.org/W2168106545","https://openalex.org/W2168691181","https://openalex.org/W2170144893","https://openalex.org/W2275877493"],"related_works":["https://openalex.org/W2162903802","https://openalex.org/W2185391357","https://openalex.org/W2460623742","https://openalex.org/W2875292493","https://openalex.org/W2360967040","https://openalex.org/W1534608409","https://openalex.org/W3000160384","https://openalex.org/W1965615508","https://openalex.org/W2945279909","https://openalex.org/W2117975608"],"abstract_inverted_index":{"Lung":[0],"cancer":[1,8,13],"accounts":[2],"for":[3,58,77,112,132,227,236,247],"a":[4,190],"quarter":[5],"of":[6,21,31,34,39,151,215,234,244],"all":[7],"deaths.":[9],"Non-small":[10],"cell":[11],"lung":[12,35],"(NSCLC)":[14],"is":[15],"currently":[16],"segregated":[17],"by":[18,147],"the":[19,40,107,138,156,242],"presence":[20],"actionable":[22],"driver":[23],"oncogenes.":[24],"This":[25],"review":[26],"will":[27,82],"provide":[28],"an":[29,181],"overview":[30],"molecular":[32],"subsets":[33,86],"cancer,":[36],"including":[37],"descriptions":[38],"defining":[41],"oncogenes":[42],"(EGFR,":[43],"ALK,":[44],"KRAS,":[45],"ROS1,":[46],"RET,":[47],"BRAF,":[48],"ERBB2,":[49],"NTRK1,":[50],"FGFR,":[51],"among":[52],"others)":[53],"and":[54,90,103,117,128,159,163,169,221],"how":[55],"these":[56,222],"predict":[57],"response":[59],"to":[60,175,201],"small":[61],"molecule":[62],"tyrosine":[63],"kinase":[64],"inhibitors":[65],"(TKIs)":[66],"that":[67,141,184],"are":[68,106,130,145,172],"either":[69],"clinically":[70],"available":[71],"or":[72],"in":[73,119,218],"clinical":[74,219],"trial":[75],"development":[76,233],"advanced":[78,135],"NSCLC.":[79,93,136,231],"Particular":[80],"focus":[81],"be":[83,186],"placed":[84],"on":[85],"with":[87,134,189,229],"EGFR":[88,96,124,142,176],"mutated":[89],"ALK":[91,178,209],"rearranged":[92],"Somatic":[94],"TKI-sensitizing":[95],"mutations":[97],"(such":[98,154],"as":[99,155],"exon":[100],"19":[101],"deletions":[102],"L858R":[104],"substitutions)":[105],"most":[108],"robust":[109],"predictive":[110],"biomarker":[111],"symptom":[113],"improvement,":[114],"radiographic":[115],"response,":[116],"increment":[118],"progression-free":[120],"survival":[121],"(PFS)":[122],"when":[123],"TKIs":[125,143,210,235],"(gefitinib,":[126],"erlotinib,":[127],"afatinib)":[129],"used":[131],"patients":[133,228],"However,":[137],"palliative":[139],"benefits":[140],"afford":[144],"limited":[146],"multiple":[148,206],"biologic":[149],"mechanisms":[150],"tumor":[152],"adaptation/resistance":[153],"EGFR-T790M":[157],"mutation":[158],"oncogene":[160],"bypass":[161],"tracks),":[162],"future":[164],"efforts":[165],"toward":[166],"delaying,":[167],"preventing,":[168],"treating":[170],"resistance":[171,200],"underway.":[173],"Similar":[174],"mutations,":[177],"rearrangements":[179],"exemplify":[180],"oncogene-driven":[182,238],"NSCLC":[183],"can":[185],"effectively":[187],"palliated":[188],"precision":[191,245],"TKI":[192,197],"therapy":[193,204],"(the":[194],"multitargeted":[195],"ALK/MET/ROS1":[196],"crizotinib).":[198],"When":[199],"first-line":[202],"crizotinib":[203],"occurs,":[205],"second":[207],"generation":[208],"have":[211],"demonstrated":[212],"impressive":[213],"rates":[214],"disease":[216],"control":[217],"trials,":[220],"may":[223,240],"modify":[224],"long-term":[225],"outcomes":[226],"ALK-positive":[230],"The":[232],"other":[237],"NSCLCs":[239],"expand":[241],"portfolio":[243],"therapies":[246],"this":[248],"recalcitrant":[249],"cancer.":[250]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2045465355","counts_by_year":[{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":16},{"year":2015,"cited_by_count":21},{"year":2014,"cited_by_count":3}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
